Headquartered in Wilmington, DE Fiscal year ends December NASDAQ: CLOV cloverhealth.com
Clover Health Investments, Corp. (Nasdaq: CLOV) is a physician enablement technology company focused on Medicare Advantage health insurance plans. The company offers PPO and HMO Medicare Advantage plans in several U.S. states, with a differentiated emphasis on wide-network, high-choice PPO plans for seniors who have historically lacked access to affordable, high-quality healthcare. Clover's strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through early identification and management of chronic disease. The company operates a full-risk Medicare Advantage model, meaning it retains the economic benefit of improved clinical outcomes. Through its subsidiary, Counterpart Health, Clover extends its data-driven technology platform to healthcare providers outside its own Medicare Advantage plan on a nationwide basis. The company has published data demonstrating the technology's impact on medication adherence, congestive heart failure, COPD, diabetes, chronic kidney disease, and underserved populations. As of Q2 2026, the company served 157,309 insurance members, representing 48% year-over-year growth. Updated
Clover Health is adding boardroom muscle just as CMS and insurers fight over 2027 Medicare Advantage rates, the single variable that decides whether this $1.9 billion insurtech keeps scaling. Board additions at a company this size shift who sets the growth-versus-margin call.
A former U.S. senator in the boardroom is political muscle for a $1.9 billion insurer whose entire business runs on Medicare Advantage rules written in Washington. With CMS tightening star ratings thresholds and rivals suing over methodology, Torricelli's Beltway access arrives exactly when it counts most.
Tempus AI closed the session up 10.5%, the only double-digit move among 111 tracked names. The downside was deeper and broader: Axon, Cava and Clover Health all gave up more than 9%.
Clover Health closed up 9.45%, the single biggest move in the 111-name priority list today. Keep an eye on the stock.
Closed up 38.1%, a move no other priority name came close to matching. Axon, Digital Turbine, Dell, Cava and SentinelOne all shed more than 6.5% in a single session.
Nearly 16 points separated the best and worst names in a 110-stock board at Monday's close, with SanDisk up 8% at $1,773 and Clover Health down almost 8%. Hardware led, small-cap growth lagged.
After years of burning cash and testing investor patience, Clover Health just posted results that bulls have been waiting for. But with medical costs creeping up and the stock already priced for…
Trey Thoelcke In this piece, we’ll check in on two mid-cap health insurance plays that are leveraging their tech-savvy and digital strengths to grab a bigger slice of the health insurance industry. Indeed, if…
Chamath Palihapitiya is a prominent venture capitalist, engineer, and entrepreneur known for his significant contributions to the tech sector. Venture capitalists were certainly among the top influencers of the post-pandemic era, when…
Chris MacDonald While special purpose acquisition companies (SPACs) have been around for years, they really burst onto the mainstream investor’s consciousness in 2020. That year there was an explosion of so-called “blank check” company…
Here is a look at one company set to report quarterly results before markets open Wednesday and three more on deck for after the markets close.
Wednesday afternoon's top analyst upgrades and downgrades included Advanced Micro Devices, Clorox, Clover Health Investments, Datadog, Electronic Arts, Etsy, General Motors, Intuitive Surgical, Starbucks and Under Armour.
EV stocks weren't the only equities to get pasted Thursday. Marijuana growers took a hit as well, but there may be some good news from Europe Friday morning.
Nearly every electric vehicle stock traded lower Thursday, as investors likely were pocketing some profits on the recent runup in these stocks.
One stock that had its moment in the meme stock sun last January has been generating some chatter lately among some retail investors.
Retail investors have some choice short squeeze targets this week and one stock, in particular, could see continued heavy volume and volatility.
Markets have been muted today with most sectors traded lower. Meme stock moves as of noon Friday have followed the same script, but the day is still young.
Thursday was mostly an up-day for meme stocks and Friday may be shaping up for more of the same.
Friday’s top analyst upgrades and downgrades included American Tower, Best Buy, Beyond Meat, Editas Medicine, Freeport McMoRan, First Solar and UnitedHealth.
Meme stocksweare lining up with the major indexes and trending lower at midday on Wednesday.
A tiny oil and gas exploration and production company was making another big move Tuesday.
Clover Health Investments, Corp. (Nasdaq: CLOV) is a physician enablement technology company focused on Medicare Advantage health insurance plans.
The Wall Street consensus 12-month price target for CLOV is $5.38.
